Patients suffering from severe coronavirus disease 2019 (COVID-19) show highly elevated levels of Gal-3, TNFα, IL-1β, and IL-6, as compared to those with moderate disease (De Biasiet al., 2020;Wanget al., 2020a). This evidence concerns the gene LGALS3 and COVID-19.